The financing was led by experienced life science investor Thairm Bio and the Scottish National Investment Bank, with participation from new and existing investors.

The Berlin-based company offers a digital safety and companion solution for older adults, addressing a problem that traditional emergency call systems have failed to solve for decades: user acceptance.

Foamlab, a Delft-based startup working to replace fossil-based plastics with high-performance foams made from bacterial cellulose, has raised €3 million in growth capital to support the construction of a pilot plant, scale up production, and speed up the commercialisation of its biobased foam materials.

Exergy3 has raised £10 million in seed funding to scale its proprietary technology addressing three of Europe’s most pressing challenges: industrial decarbonisation, grid balancing and energy security.

Eka VC announced the final close of its second fund at $107 million (£80 million). This milestone cements Eka’s position as the UK’s largest early-stage impact investor focused on the intersection of health, wellbeing, and sustainability.

neuroClues announces a €10 million Series A to accelerate one of the fastest clinical rollouts in European neurotech, while concurrently securing additional non-dilutive funding, bringing the total capital raised by neuroClues to €25 million.

Pisa-based startup Wearable Robotics has raised €5 million in a Series A funding round to accelerate international growth and advance its wearable robotics solutions for neuromotor rehabilitation.

Enkei is a Swedish startup founded by Lovisa Sunnerholm and Miriam Bichsel, to turn construction and ceramic waste into new, high-quality materials that can be used in architecture and interior design.

VitaminºC, a new venture capital firm, announced the first close of its €18M ($20M) debut early-stage climate fund.

360 Capital has announced the closing of €85 million for Poli360 2, its second deeptech technology transfer fund, targeting a total of €100 million.